Jad Fakhry, 10% Owner at NovaBay Pharmaceuticals, Inc. (NBY), bought 49,927 shares at $0.60 ($31K) on 2025-03-19, disclosed to the SEC on 2025-04-15.
Open-market purchase of $31k NBY by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.63 | 14,000 | $9K | 28.7% |
| 2 | $0.60 | 1,500 | $900 | 2.9% |
| 3 | $0.61 | 5,320 | $3K | 10.6% |
| 4 | $0.61 | 6,372 | $4K | 12.7% |
| 5 | $0.61 | 100 | $61 | 0.2% |
| 6 | $0.61 | 22,635 |
| $14K |
| 44.9% |
| Total | $0.62 avg | 49,927 | $31K | 100% |
| Filing → |
| NBY | BUY | 2025-04-15 | $16K | — | Filing → |
| SWSH | BUY | 2016-05-17 | $97K | — | Filing → |